TP53 and neoplasm: TP53 mutations are found at a higher frequency in individuals of AFA relative to individuals of EUR tumors in multiple tumor types (lung, colon, gastric, human papilloma virus–negative head and neck), suggesting that genetic background and/or differences in exposures/socio-determinants of health may influence selection of TP53 somatic mutations (71–74).